NO770286L - Fremgangsm}te til fremstilling av dinatriumkromglycat. - Google Patents

Fremgangsm}te til fremstilling av dinatriumkromglycat.

Info

Publication number
NO770286L
NO770286L NO770286A NO770286A NO770286L NO 770286 L NO770286 L NO 770286L NO 770286 A NO770286 A NO 770286A NO 770286 A NO770286 A NO 770286A NO 770286 L NO770286 L NO 770286L
Authority
NO
Norway
Prior art keywords
dinatrium
glycate
chrome
procedures
preparation
Prior art date
Application number
NO770286A
Other languages
English (en)
Other versions
NO151860C (no
NO151860B (no
Inventor
Kenneth Brown
Neil Arthur Stevenson
William Francis Kirk
Clive Booles
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26238506&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO770286(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB3672/76A external-priority patent/GB1562901A/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of NO770286L publication Critical patent/NO770286L/no
Publication of NO151860B publication Critical patent/NO151860B/no
Publication of NO151860C publication Critical patent/NO151860C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
NO770286A 1976-01-30 1977-01-28 Fremgangsmaate for fremstilling av dinatriumsaltet av 1,3-bis-(2-karboksykromon-5-yloksy)propan-2-ol NO151860C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3672/76A GB1562901A (en) 1976-01-30 1976-01-30 Disodium cromoglycate
GB5113676 1976-12-08

Publications (3)

Publication Number Publication Date
NO770286L true NO770286L (no) 1977-08-02
NO151860B NO151860B (no) 1985-03-11
NO151860C NO151860C (no) 1985-06-19

Family

ID=26238506

Family Applications (2)

Application Number Title Priority Date Filing Date
NO770286A NO151860C (no) 1976-01-30 1977-01-28 Fremgangsmaate for fremstilling av dinatriumsaltet av 1,3-bis-(2-karboksykromon-5-yloksy)propan-2-ol
NO780183A NO780183L (no) 1976-01-30 1978-01-18 Fremgangsm}te til fremstilling av et dinatrium-kromoglykatmateriale

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO780183A NO780183L (no) 1976-01-30 1978-01-18 Fremgangsm}te til fremstilling av et dinatrium-kromoglykatmateriale

Country Status (14)

Country Link
JP (1) JPS5294411A (no)
AU (1) AU512593B2 (no)
DE (1) DE2703119A1 (no)
DK (2) DK154766C (no)
ES (1) ES455478A1 (no)
FI (1) FI770215A (no)
FR (1) FR2339604A1 (no)
IE (1) IE44760B1 (no)
IL (1) IL51314A (no)
LU (1) LU76661A1 (no)
NL (1) NL185446C (no)
NO (2) NO151860C (no)
NZ (1) NZ183157A (no)
SE (2) SE442268B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU522792B2 (en) * 1977-07-19 1982-06-24 Fisons Plc Pressure pack formulation
CY1333A (en) * 1980-04-30 1986-10-24 Fisons Ltd Pharmaceutical compositions containing cromoglycates
ZA812811B (en) * 1980-04-30 1982-06-30 Fisons Ltd Mixtures and salts of beta-2 selective bronchodilators with cromoglycic acid and salts thereof
JPS63138228U (no) * 1987-03-05 1988-09-12
JPS63138229U (no) * 1987-03-05 1988-09-12
GB8819490D0 (en) * 1988-08-16 1988-09-21 Fisons Plc Pharmaceutical devices
DE68915203T2 (de) * 1988-03-22 1994-09-22 Fisons Plc Pharmazeutische Mischungen.
GB8829478D0 (en) * 1988-12-16 1989-02-01 Harris Pharma Ltd Formulations
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
JP3280974B2 (ja) * 1991-12-12 2002-05-13 グラクソ、グループ、リミテッド 医 薬
CA2125666C (en) 1991-12-12 2002-07-16 Rachel Ann Akehurst Medicaments
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
NZ246421A (en) 1991-12-18 1996-05-28 Minnesota Mining & Mfg Aerosol formulation containing a drug and a propellant and which is substantially free of surfactant
NZ509328A (en) 1998-07-24 2002-11-26 Jago Res A Medicinal aerosol formulations
ES2193726T3 (es) 1998-08-04 2003-11-01 Jago Res Ag Formulaciones de aerosol medicinales.
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
KR20090129998A (ko) 2007-02-11 2009-12-17 맵 파마슈티컬스, 인코포레이티드 부작용 프로파일을 최소화하면서 편두통의 빠른 완화를 가능하게 하는 ｄｈｅ의 치료적 투여 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (no) * 1956-03-21 1900-01-01
BE556587A (no) * 1957-01-31 1957-04-11
GB1063512A (en) * 1962-11-30 1967-03-30 Benger Lab Ltd Aerosols
US3282791A (en) * 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
IL44022A0 (en) * 1973-01-23 1974-05-16 Fisons Ltd Novel salts of anti-inflammatory quinoline derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
IL51314A0 (en) 1977-03-31
DE2703119A1 (de) 1977-08-04
DK154766B (da) 1988-12-19
NO780183L (no) 1977-08-02
DK357588D0 (da) 1988-06-29
JPS6129929B2 (no) 1986-07-10
NL185446C (nl) 1990-04-17
NL185446B (nl) 1989-11-16
DK154766C (da) 1989-05-22
FI770215A (no) 1977-07-31
SE442268B (sv) 1985-12-16
NL7700911A (nl) 1977-08-02
DK38077A (da) 1977-07-31
JPS5294411A (en) 1977-08-09
LU76661A1 (no) 1977-08-03
NZ183157A (en) 1979-08-31
DK357588A (da) 1988-06-29
FR2339604A1 (fr) 1977-08-26
AU2162677A (en) 1978-08-03
IE44760B1 (en) 1982-03-24
AU512593B2 (en) 1980-10-16
DK156876C (da) 1990-03-12
SE8107278L (sv) 1981-12-04
FR2339604B1 (no) 1980-12-05
SE442267B (sv) 1985-12-16
NO151860C (no) 1985-06-19
IE44760L (en) 1977-07-30
ES455478A1 (es) 1978-02-01
NO151860B (no) 1985-03-11
IL51314A (en) 1980-03-31
DE2703119C2 (no) 1990-10-25
DK156876B (da) 1989-10-16
SE7700888L (sv) 1977-07-31

Similar Documents

Publication Publication Date Title
NO770286L (no) Fremgangsm}te til fremstilling av dinatriumkromglycat.
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
NO147386C (no) Fremgangsmaate for fremstilling av forbedrete bitumer/polymerblandinger.
NO147751C (no) Fremgangsmaate til fremstilling av 4-hydroksypyrrolidin-2-on-amider.
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
NO770366L (no) Fremgangsm}te for fremstilling av meta-aryloksy-benzaldehyder.
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO770183L (no) Fremgangsm}te for fremstilling av heksanitrostilben.
NO151365C (no) Fremgangsmaate for fremstilling av 4-halogen-dihydropyran-derivater.
NO771159L (no) Fremgangsm}te ved fremstilling av titantetraklorid.
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
NO152645C (no) Fremgangsmaate for fremstilling av klordioksyd.
DK139029B (da) Analogifremgangsmåde til fremstilling af 5-m-tolyloxyuracil.
NO771870L (no) Fremgangsm}te for fremstilling av 3,4-dihydro-2-metyl-4-okso-2h-1,2-benzotiazin-3-karboksylsyre-1,1-dioksyd
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
NO147600C (no) Fremgangsmaate til fremstilling av tereftalsyre.
SE7707811L (sv) Forfarande for framstellning av p.isobutyl-hydratropat av guajakol
NO770545L (no) Fremgangsm}te ved fremstilling av 2,9-dioxatricyclo-(4.3.1.0)-decaner.
NO770673L (no) Fremgangsm}te for fremstilling av benzylestere.
DK368877A (da) Fremgangsmaade til fremstilling af aryloxy-1-amino-3-propanoler-2.
SE7702068L (sv) Forfarande for framstellning av halogenacetaler av eteniska aldehyder
NO772809L (no) Fremgangsm}te for fremstilling av 2,6-diterti{rt-butylfenol
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
NO144067C (no) Fremgangsmaate for fremstilling av di-n-propylacetonitril.